PROMPERÚ
21.4.2022 23:23:12 CEST | Business Wire | Press release
From April 5 to 7, Peru was represented in Berlin at the latest edition of Fruit Logistica 2022, the world's leading fresh fruit and vegetable fair, reports the Commission for the Promotion of Peru for Exports and Tourism (PROMPERÚ).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220416005003/en/
“This time around, Peru's business objective at Fruit Logistica will be to achieve 200 million USD in prospective business for the next 12 months and to generate 6,000 business contacts with the Peruvian delegation, in addition to consolidating a diversified and quality exportable supply,” stated the executive president of PROMPERÚ, Amora Carbajal.
“The sustainability of the Peruvian exportable supply will be a differentiating element at the fair. This is a focus that has been developing within our society and within the business models of Peruvian agro-export companies, improving their competitiveness and reducing environmental impacts through responsible water management, efficient carbon footprint management and fair trade strategies,” said the head of PROMPERÚ.
Fruit Logistica 2022 made it possible to consolidate the position of the Super Food Peru, Pisco, Spirit of Peru and Cafés del Perú brands. The commercial promotion campaign included activations and sampling of exotic fruits and specialty coffees in the national pavilion, in addition to pisco tastings, and typical regional dances.
The delegation led by PROMPERÚ was made up of the Ministry of Agriculture and Irrigation (MIDAGRI), Sierra and Selva Exportadora, Agro Ideas, the Embassy of Peru in Germany, directors of unions and the Association of Agricultural Producer Unions of Peru (AGAP).
Exports
Peruvian food sector exports to the European Union in 2021 reached 3,432 billion USD, growing by more than 13%. The main exports include fresh and dried avocados (604 million USD / +32.3%), unroasted coffee (422 million USD / +23.9%), fresh blueberries (360 million USD / +7.0%), fresh grapes (306 million USD / +28.3%), fresh mangoes (175 million USD / +0.7%), among other products.
In addition, foreign sales of fruit and vegetables amounted to 2,103 billion USD in this same period, with a growth of more than 17%, due to the notable performance of the Netherlands (1,132 billion USD / +19.6%), the United Kingdom (346 million USD / +9.4%), Spain (324 million USD / +22.5%) and Germany (56 million USD / +24.5%). These markets make up 95% of the value exported to the European Union.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220416005003/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Curatis: Double-Digit Revenue Growth in 2025 and Major Milestones for Corticorelin Achieved24.3.2026 07:00:00 CET | Press release
Curatis Holding AG (SIX:CURN, “Curatis”) reports business revenues of CHF 10.8m (+57%) for 2025. Curatis AG increased sales in its distribution business organically by 13%, from CHF 9.5m to CHF 10.8m. The net result improved from a loss of CHF 4.3m in 2024 to a loss of CHF 1.4m in 2025. Further key statements In September 2025, our development plan for corticorelin was validated at a meeting with the FDA, enabling Curatis to proceed toward a regulatory submission supporting a pivotal study in patients suffering from peritumoral brain edema (PTBE). In November 2025, Curatis raised CHF 1.2m to progress corticorelin. The cash position as of year end 2025 was comfortable, standing at CHF 1.9m. Recently, Curatis announced a license agreement for corticorelin for Japan with significant milestone payments. Business development and finances In 2025, product sales amounted to CHF 10.3m, while service revenue amounted to CHF 0.5m. On a full year basis, Curatis AG increased revenues in its distri
AAD 2026: Galderma Showcases Latest Evidence Supporting Its Full-Spectrum, Science-Driven Solutions for Diverse Skin Needs24.3.2026 07:00:00 CET | Press release
From its Therapeutic Dermatology portfolio, Galderma will present data on the efficacy and safety of Nemluvio® (nemolizumab) in different patient populations with moderate-to-severe atopic dermatitis, including late-breaking data in pediatric patients, and share four posters on AKLIEF® (trifarotene)1-8 Additional presentations related to Dermatological Skincare will explore how artificial intelligence can identify high-risk factors for sensitive skin and Cetaphil® in different skin types9 Data from Galderma’s Injectable Aesthetics portfolio will also show how its hyaluronic acid injectables, Restylane®, and neuromodulator, RelabotulinumtoxinA*, may address aesthetic needs across the face and décolletage10-14 A total of 22 presentations will reinforce the value of Galderma’s broad and comprehensive portfolio in meeting varied patient needs across Therapeutic Dermatology, Injectable Aesthetics and Dermatological Skincare Galderma (SIX: GALD), the pure-play dermatology category leader, wi
Avanzanite Expands French Operations and Appoints Constance Sabbagh as General Manager24.3.2026 07:00:00 CET | Press release
Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today announced its expansion into France, Europe’s second largest economy, and the appointment of Constance Sabbagh as General Manager, France. Following a €32 million Series A investment by MVM Partners announced in November 2025, Avanzanite is scaling its European infrastructure into a single, integrated platform across 32 countries – designed to bring rare disease medicines to patients in every European market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260323639110/en/ Constance Sabbagh, General Manager, France “France is essential to Avanzanite’s European vision,” said Adam Plich, Co-founder and CEO of Avanzanite. “With its leadership in rare disease policy through its National Rare Disease Plans, care networks and scientific innovation, France is one of the most significant healthcare
HJS Foundation Releases JEP Protocol & HJS Framework: The "Black Box" for AI, Enabling Verifiable Human Oversight24.3.2026 04:36:00 CET | Press release
HJS Foundation (Human Judgment Systems Foundation) today released two complementary solutions: the Judgment Event Protocol (JEP) and the Human Judgment Structure (HJS) framework. As a minimalist open standard, JEP generates tamper-proof records of AI decision accountability, just like an aircraft black box; HJS embeds human judgment logic into AI operation processes — together, they transform "human oversight" from a regulatory requirement into a verifiable technical fact, providing an optional technical solution for AI accountability. How to prove that AI decisions (such as loan approvals, medical diagnoses, border screenings, etc.) have undergone human review? JEP generates immutable audit trails of human intervention through four cryptographic primitives — Judge, Verify, Delegate, Terminate; HJS builds a controllable and accountable system to prevent risks such as AI drift and ensure that human judgment guides AI operations. Current systems rely on alterable post-hoc documentation,
Power Integrations Extends Flyback Topology to Enable 440 W, Offering Simpler Alternatives to Resonant Power Designs23.3.2026 22:45:00 CET | Press release
New TOPSwitchGaN ICs more than double power output, reducing system cost, complexity, and design time APEC 2026 – Power Integrations (NASDAQ: POWI), the leader in high-voltage integrated circuits for energy-efficient power conversion, today introduced a breakthrough in flyback topology extending the power range of flyback converters to 440 W—well beyond the limits that traditionally required more complex resonant and LLC topologies. The new TOPSwitchGaN™ flyback IC family unites the company’s groundbreaking PowiGaN™ technology with its iconic TOPSwitch™ IC architecture, reducing complexity, eliminating heat sinks in many cases, shortening design time, improving manufacturability, and lowering total system cost. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260323686299/en/ The new TOPSwitchGaN™ flyback IC family extends the power range of flyback converters to 440 W—well beyond the limits that traditionally required more co
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom